Journal of Clinical Oncology

Erratum: Efficacy and Safety of Anselamimab in Immunoglobulin Light Chain Amyloidosis: Results From the Randomized CARES Trials

A Ashutosh D. Wechalekar (National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom.) A Angela Dispenzieri V Vaishali Sanchorawala (Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, Massachusetts, United States) E Efstathios Kastritis D Divaya Bhutani (Columbia University Medical Center, New York) G Giada Bianchi V Victor H. Jimenez-Zepeda K Kenshi Suzuki S Suzanne Lentzsch (Columbia University Medical Center, New York, New York, United States) A Antoine Huart (Department of Nephrology and Transplantation, Toulouse Amyloidosis Center, Toulouse, France) A Alexander Carpinteiro E Eugene Scott Swenson Z Zilehuma Khan J Julia Catini H Hrishikesh Kulkarni (UCLA) B Brian Meltzer S Stephen Lake M Michaela Liedtke
View Original
APA MLA Chicago BibTeX RIS

Article Details

Volume / Issue Vol. 1, Issue 1
Published August 03, 2026
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences

Authors (18)

A

Ashutosh D. Wechalekar

National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom.

A

Angela Dispenzieri

V

Vaishali Sanchorawala

Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, Massachusetts, United States

E

Efstathios Kastritis

D

Divaya Bhutani

Columbia University Medical Center, New York

G

Giada Bianchi

V

Victor H. Jimenez-Zepeda

K

Kenshi Suzuki

S

Suzanne Lentzsch

Columbia University Medical Center, New York, New York, United States

A

Antoine Huart

Department of Nephrology and Transplantation, Toulouse Amyloidosis Center, Toulouse, France

A

Alexander Carpinteiro

E

Eugene Scott Swenson

Z

Zilehuma Khan

J

Julia Catini

H

Hrishikesh Kulkarni

UCLA

B

Brian Meltzer

S

Stephen Lake

M

Michaela Liedtke

Related Articles from this Journal

Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Ismaela Anna Vascotto, Filippo Antonica et al. Aug 2026 10.1200/jco-26-00658

Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial

Samer A. Srour, Jad Chahoud et al. Aug 2026 10.1200/jco-26-00388

Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection

Risako Komata, Kenju Ando et al. Aug 2026 10.1200/jco-26-00140

Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)

Ghayas C. Issa, Branko Cuglievan et al. Aug 2026 10.1200/jco-26-01743

Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Irbaz Bin Riaz, R. Bryan Rumble et al. Aug 2026 10.1200/jco-26-01001